MRK vs IDXX
By Alex · Tickerpine
Merck & Co., Inc. vs IDEXX Laboratories, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | IDXX |
|---|---|---|
| Price | $147.76 | $704.23 |
| Market cap | $364.26B | $55.48B |
| P/E ratio | 149.3 | 47.5 |
| ROE | 5.06% | 68.93% |
| Profit margin | 3.64% | 25.36% |
| Revenue growth | 4.70% | 9.90% |
| Dividend yield | 2.30% | 0.00% |
| Beta | 0.12 | 1.54 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs IDXX in plain English
- MRK is the bigger company — about 6.6× the market cap of IDXX.
- IDXX is cheaper on earnings (P/E 47.5 vs 149.3).
- IDXX earns a higher return on equity (69% vs 5%).
- IDXX is growing revenue faster (10% vs 5%).
- MRK pays a dividend (2.30%) while the other effectively doesn't.
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
IDXX return calculator
See what $1,000 in IDEXX Laboratories, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.